SCHEMBL22288671

SCHEMBL22288671

COC(=O)CNC(=S)c1ccc(OCc2ccccc2)c(C(F)(F)F)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXRA P19793 4/20 0.51
RXRB P28702 4/20 0.51
RXRG P48443 4/20 0.51
MRGPRX4 Q96LA9 7/20 0.50
SMPD1 P17405 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PPARG P37231 1/20 0.42
PPARD Q03181 1/20 0.42
PTPN7 P35236 1/20 0.41
DUSP3 P51452 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22288724 0.89 RXRA (0.53) RXRARXRBRXRGMRGPRX4SMPD1
SCHEMBL3901919 0.83 MRGPRX4 (0.69) RXRARXRBRXRGMRGPRX4SMPD1
SCHEMBL1437991 0.80 RXRA (0.61) RXRARXRBRXRGMRGPRX4SMPD1
SCHEMBL3550858 0.80 RXRA (0.57) RXRARXRBRXRGMRGPRX4NPC1
SCHEMBL79709 0.80 RXRA (0.72) RXRARXRBRXRGMRGPRX4MEN1
SCHEMBL22308853 0.80 BRD4 (0.61) RXRARXRBRXRGMRGPRX4SMPD1
SCHEMBL2950475 0.78 RXRA (0.59) RXRARXRBRXRGMRGPRX4SMPD1
SCHEMBL22309140 0.78 PTPN7 (0.55) HDAC8SMN1; SMN2PPARDPTPN7DUSP3
SCHEMBL10323581 0.78 RXRA (0.61) RXRARXRBRXRGMRGPRX4SMPD1
SCHEMBL22288718 0.78 NOTUM (0.49) NPC1RAB9ASMN1; SMN2PTPN7DUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020157189-A1 1,2,4-TRIAZIN-6(1H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2020-08-06 WO disclosed
WO-2020157189-A1 1,2,4-TRIAZIN-6(1H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2020-08-06 WO disclosed